![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Wild, C. (2003): [High-dose lymphoablative therapy (HDLT) for severe autoimmune diseases]. HTA-Newsletter 21: pp. 2-3.
Preview |
PDF (HTA-Newsletter 21)
- Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
167kB |
Official URL: http://hw.oeaw.ac.at/ita/hta-newsletter?frames=yes
| Item Type: | HTA Newsletter Item |
|---|---|
| Keywords: | High dose ymphoablative therapy (HDLT), severe autoimmune diseases, immune system, autologous stem cell transplantation, cyclophosphamide |
| Subjects: | WD Disorders of systemic, metabolic or environmental origin > WD 300-375 Immunologic and collagen diseases QV Pharmacology, toxicology, pharmacy > QV 247-269 Anti-inflammatory agents. Anti-infective agents WO Surgery > WO 660-690 Transplantation |
| Related URLs: | |
| Language: | German |
| Number: | 21 |
| Deposited on: | 04 Jan 2008 18:57 |
| Last Modified: | 15 Jul 2020 17:24 |
Repository Staff Only: item control page